135 related articles for article (PubMed ID: 12704593)
1. Treatment of gammaherpesvirus-related neoplastic disorders in the immunosuppressed host.
Little RF; Yarchoan R
Semin Hematol; 2003 Apr; 40(2):163-71. PubMed ID: 12704593
[TBL] [Abstract][Full Text] [Related]
2. Molecular biology of Epstein-Barr virus and Kaposi's sarcoma-associated herpesvirus.
Swaminathan S
Semin Hematol; 2003 Apr; 40(2):107-15. PubMed ID: 12704587
[TBL] [Abstract][Full Text] [Related]
3. Fatal lymphoproliferative disease associated with a novel gammaherpesvirus in a captive population of common marmosets.
Ramer JC; Garber RL; Steele KE; Boyson JF; O'Rourke C; Thomson JA
Comp Med; 2000 Feb; 50(1):59-68. PubMed ID: 10987671
[TBL] [Abstract][Full Text] [Related]
4. Complete absence of KSHV/HHV-8 in posttransplant lymphoproliferative disorders: an immunohistochemical and molecular study of 52 cases.
Chen W; Huang Q; Zuppan CW; Rowsell EH; Cao JD; Weiss LM; Wang J
Am J Clin Pathol; 2009 May; 131(5):632-9. PubMed ID: 19369621
[TBL] [Abstract][Full Text] [Related]
5. Gammaherpesvirus and lymphoproliferative disorders in immunocompromised patients.
Cesarman E
Cancer Lett; 2011 Jun; 305(2):163-74. PubMed ID: 21493001
[TBL] [Abstract][Full Text] [Related]
6. Overview of posttransplant B-cell lymphoproliferative disorders.
Swinnen LJ
Semin Oncol; 1999 Oct; 26(5 Suppl 14):21-5. PubMed ID: 10561014
[TBL] [Abstract][Full Text] [Related]
7. Lymphoproliferative disorders and other tumors complicating immunodeficiencies.
Filipovich AH; Mathur A; Kamat D; Kersey JH; Shapiro RS
Immunodeficiency; 1994; 5(2):91-112. PubMed ID: 8032367
[TBL] [Abstract][Full Text] [Related]
8. Gammaherpesviruses and lymphoproliferative disorders.
Cesarman E
Annu Rev Pathol; 2014; 9():349-72. PubMed ID: 24111911
[TBL] [Abstract][Full Text] [Related]
9. Bcl-2 antisense (G3139, Genasense) enhances the in vitro and in vivo response of Epstein-Barr virus-associated lymphoproliferative disease to rituximab.
Loomis R; Carbone R; Reiss M; Lacy J
Clin Cancer Res; 2003 May; 9(5):1931-9. PubMed ID: 12738752
[TBL] [Abstract][Full Text] [Related]
10. Advanced therapeutic and prophylactic strategies for Epstein-Barr virus infection in immunocompromised patients.
Okano M; Gross TG
Expert Rev Anti Infect Ther; 2007 Jun; 5(3):403-13. PubMed ID: 17547505
[TBL] [Abstract][Full Text] [Related]
11. Murine gammaherpesvirus 68: a model for the study of Epstein-Barr virus infections and related diseases.
Olivadoti M; Toth LA; Weinberg J; Opp MR
Comp Med; 2007 Feb; 57(1):44-50. PubMed ID: 17348290
[TBL] [Abstract][Full Text] [Related]
12. A murine gammaherpesvirus.
Mistríková J; Raslová H; Mrmusová M; Kúdelová M
Acta Virol; 2000; 44(3):211-26. PubMed ID: 11155368
[TBL] [Abstract][Full Text] [Related]
13. Epstein-Barr virus-associated lymphoproliferative disorders.
Ambinder RF
Rev Clin Exp Hematol; 2003 Dec; 7(4):362-74. PubMed ID: 15129648
[TBL] [Abstract][Full Text] [Related]
14. Epstein-Barr virus-specific cytotoxic T-lymphocytes for adoptive immunotherapy of post-transplant lymphoproliferative disease.
Burns DM; Crawford DH
Blood Rev; 2004 Sep; 18(3):193-209. PubMed ID: 15183903
[TBL] [Abstract][Full Text] [Related]
15. Tumor origin and CD20 expression in posttransplant lymphoproliferative disorder occurring in solid organ transplant recipients: implications for immune-based therapy.
Gulley ML; Swinnen LJ; Plaisance KT; Schnell C; Grogan TM; Schneider BG;
Transplantation; 2003 Sep; 76(6):959-64. PubMed ID: 14508361
[TBL] [Abstract][Full Text] [Related]
16. Murine Gammaherpesvirus 68: A Small Animal Model for Gammaherpesvirus-Associated Diseases.
Dong S; Forrest JC; Liang X
Adv Exp Med Biol; 2017; 1018():225-236. PubMed ID: 29052141
[TBL] [Abstract][Full Text] [Related]
17. Immune-cell treatment of Epstein--Barr-virus-associated lymphoproliferative disorders.
Swinnen LJ
Best Pract Res Clin Haematol; 2006; 19(4):839-47. PubMed ID: 16997187
[TBL] [Abstract][Full Text] [Related]
18. Analysis of genomic homology of murine gammaherpesvirus (MHV)-72 to MHV-68 and impact of MHV-72 on the survival and tumorigenesis in the MHV-72-infected CB17 scid/scid and CB17+/+ mice.
Oda W; Mistrikova J; Stancekova M; Dutia BM; Nash AA; Takahata H; Jin Z; Oka T; Hayashi K
Pathol Int; 2005 Sep; 55(9):558-68. PubMed ID: 16143031
[TBL] [Abstract][Full Text] [Related]
19. Microenvironmental abnormalities induced by viral cooperation: Impact on lymphomagenesis.
De Paoli P; Carbone A
Semin Cancer Biol; 2015 Oct; 34():70-80. PubMed ID: 25837157
[TBL] [Abstract][Full Text] [Related]
20. Primary cutaneous Epstein-Barr virus-related lymphoproliferative disorders in 4 immunosuppressed children.
Wallet-Faber N; Bodemer C; Blanche S; Delabesse E; Eschard C; Brousse N; Fraitag S
J Am Acad Dermatol; 2008 Jan; 58(1):74-80. PubMed ID: 17884243
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
